Skip to content
AlternativeMed
Holistic Remedies · Ingredient

Myoinositol

Formula: C6H12O6 · MW: 180.156 · Drug-likeness: 0.227

⚗️ Identity
Name
Myoinositol
Aliases / Synonyms
inositol; myo-inositol; Scyllo-inositol; epi-Inositol; Muco-Inositol; Allo-inositol; i-Inositol; 87-89-8; meso-Inositol; D-chiro-Inositol
🧪 Chemistry
Molecular Weight
180.1560
LogP
-3.8346
Drug-likeness
0.227
H-Bond Acceptors
6
H-Bond Donors
6
🔗 External References
PubChem CID
InChIKey
CDAISMWEOUEBRE-UHFFFAOYSA-N
44
Clinical Trials
9
Meta-Analyses
3
PubMed References
📋 Sample Trials
NCT04745780
Evaluation of Efficacy and Safety of a Combination Containing Myo-inositol, D-chiro-inositol, Alpha-lactalbumin, Zinc and Extract of Gymnema Sylvestre in Subjects Diabetic Patients.
Completed · Type 2 Diabetes
NCT01115127
Myo-inositol and Melatonin in Pre-menopausal Women
Completed · Phase 2|Phase 3 · Pre-menopausal Irregular Cycles and Blee
NCT00061997
Inositol in Preventing Lung Cancer in Patients With Bronchial Epithelial Dysplasia Who Are Current or Former Smokers
Completed · Phase 1 · Lung Cancer|Precancerous Condition
NCT00349726
Single-Dose Intravenous Inositol Pharmacokinetics in Preterm Infants
Completed · Phase 2 · Infant, Newborn|Infant, Low Birth Weight
NCT00452829
Prevention of Neural Tube Defects by Inositol in Conjunction With Folic Acid (PONTI Study)
Completed · Phase 1 · Recurrent Neural Tube Defects
NCT00783705
Inositol in Preventing Lung Cancer in Current or Former Smokers With Bronchial Dysplasia
Completed · Phase 2 · Non-small Cell Lung Cancer|Squamous Lung
📊 Sample Meta-Analyses
CRD42017082275
Systematic review and meta-analysis of trials comparing markers of ovarian reserve and treatment outcomes following treatment with myo-inositol/di-chiro-inositol versus placebo/no treatment in women with polycystic ovary syndrome (PCOS) undergoing in-vitro fertilisation/intra-cytoplasmic sperm injection (IVF/ICSI) treatment.
Assisted Reproductive Technology. Polycystic Ovary Syndrome.
CRD42022380602
Study of comparative effectiveness and safety of metformin, myoinositol, life style changes and herbal medicines in improving endocrine and clinical variables in management PCOS patients a systematic review and a network meta-analysis.
Polycystic ovarian syndrome (PCOS) is the most common reason of infertility affe
CRD42023449705
Clinical Comparative Efficacy and Therapeutic Strategies for the Hashimoto's Thyroiditis: a Systematic Review and Network Meta-analysis.
Hashimoto’s thyroiditis (HT) is an autoimmune disease that destroys thyroid cell
CRD42023424883
Investigating the efficacy of natural products on metabolism and on endocrine status in women with PCOS
Polycystic ovarian syndrome (PCOS) is one of the most common endocrine disorders
CRD42023459005
Role of dietary supplements in type 2 diabetes mellitus with coronary heart disease: a systematic review and network meta-analysis
Outcomes associated with populations in type 2 diabetes mellitus with coronary h
CRD42023441257
Comparison of nutritional supplements in improving glycolipid metabolism and endocrine function in polycystic ovary syndrome: A systematic review and network meta-analysis
Polycystic ovary syndrome (PCOS) is a common gynecological Endocrine disease, af
📚 Sample References
PMID 34665453
The effect of metformin and myoinositol on metabolic outcomes in women with polycystic ovary syndrome: role of body mass and adiponectin in a randomized controlled trial
J Endocrinol Invest · 2021
PMID 35163126
Myo-Inositol Limits Kainic Acid-Induced Epileptogenesis in Rats
Int J Mol Sci · 2022
PMID 36611810
Myo-Inositol Supplementation Alleviates Cisplatin-Induced Acute Kidney Injury via Inhibition of Ferroptosis
Cells · 2023